While most of the effort in the field of cancer immunotherapy has been focused on immune checkpoint receptors, inhibiting the function of P-gp by antibodies could re-sensitize cancer cells to potent chemotherapy drugs which otherwise are pumped out of the cells. Here, PGP is linked to cancer.